Reaping Value-Added Benefits from Crowdfunders: What Can We Learn from Relationship Marketing?
نویسندگان
چکیده
منابع مشابه
What can we learn from drug marketing efficiency?
Institutions responsible for monitoring drug safety have been criticised widely after the withdrawal of drugs such as rofecoxib because of safety concerns. An estimated 20 million patients received prescriptions for rofecoxib over five years before the drug was withdrawn, and events attributable to rofecoxib may number in tens to hundreds of thousands. Regulatory bodies such as the US Food and ...
متن کاملReaping Relationship Marketing Benefits from Corporate Social Initiatives
Corporate Social Responsibility (CSR) is very prominent on the corporate agenda. Our research examines the individual-level dynamics of how a brand’s social initiatives can generate relationship marketing benefits. We find that positive CSR beliefs strengthen consumers’ relationships with the brand, generating benefits for the brand such as greater likelihood of purchase, increased loyalty, and...
متن کاملWhat Can We Learn from 21 Years of School Poisonings in New Zealand?
Background: Childhood poisoning is a significant international health concern. Very little is known about trends in exposures within schools and preschools. The objectives of this study were to investigate the data recorded by the New Zealand National Poisons Centre (NPC) on these types of exposures over a 21 year period (1989 to 2009) and to determine trends and propose strategies to reduce th...
متن کاملWhat we can learn from atmospheric neutrinos
Physics potential of future measurements of atmospheric neutrinos is explored. Observation of ∆m221 driven sub-dominant effects and θ13 driven large matter effects in atmospheric neutrinos can be used to study the deviation of θ23 from maximality and its octant. Neutrino mass hierarchy can be determined extremely well due to the large matter effects. New physics can be constrained both in stand...
متن کاملWhat can we learn from Europe?
The European Society of Cardiology has produced guidelines for the treatment of acute myocardial infarction as well as for chronic heart failure and for the use of beta blockers and angiotensin converting enzyme inhibitors. These documents provide clear evidence and strength of recommendations for the secondary prevention of complications after a myocardial infarction. The identification of hea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Strategic Change
سال: 2014
ISSN: 1086-1718
DOI: 10.1002/jsc.1988